Authors : Inderpreet Singh; Akanksha Sharma; Sanjiv Duggal

Volume/Issue : Volume 11 - 2026, Issue 5 - May

Google Scholar : https://tinyurl.com/49t8et9w

Scribd : https://tinyurl.com/5n7fxyb7

DOI : https://doi.org/10.38124/ijisrt/26May558

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : In the pharmaceutical industry, quality control (QC) testing of tablets and capsules is a crucial procedure to guarantee that pharmaceutical goods fulfill predetermined standards for safety, efficacy, and quality prior to being put on the market. Since these dosage forms are among the most commonly utilized in healthcare, it is essential to uphold stringent quality standards in order to safeguard patient health and adhere to legal requirements .Official pharmacopoeia tests and unofficial evaluations are combined in QC testing to confirm the product's identity, strength, purity, and functionality. Weight variation, hardness, friability, disintegration time, dissolution profile, content uniformity, and assay of the active pharmaceutical ingredient (API) are among the official tests listed in pharmacopeias like the Indian Pharmacopoeia (IP), United States Pharmacopoeia (USP), and British Pharmacopoeia (BP). These factors guarantee consistent dose, stability, mechanical strength, and bioavailability. Organoleptic examination, physical appearance inspection, and defect analysis are examples of non-official or supplemental testing that help find problems like cracks, discolouration, or coating flaws that may affect patient acceptability and product stability. To guarantee uniformity and traceability, regulatory bodies mandate that all quality control operations adhere to Good Manufacturing Practices (GMP).

Keywords : Pharmaceutical Tablets, Pharmacopoeia, Weight Fluctuation, Hardness, Friability, Dissolution, and Disintegration Time.

References :

1. Aulton ME, Taylor K, editors. Aulton's pharmaceutics: the design and manufacture of medicines. Elsevier Health Sciences; 2013.
2. Raikwar S, Bidla PD, Jain SK. Optimization Techniques for the Development of Pharmaceutical. Advances in Pharmaceutical Product Development. 2025 Mar p18-55.
3. Ace Jr LN. Pharmaceutical dosage forms and drug delivery systems. American Journal of Pharmaceutical Education. 2001 Apr 1;65(1):104.
4. 4 Yang Y, Liu Y, Zhang X, Wu⁴ X, Gong Y, Wang X, Li F, Qin10 H. education for primary school. Reducing preventable deaths: Health education and policy. 2023 Jul, p27-166.
5. United States Pharmacopeial Convention. Committee of Revision. United States Pharmacopeia, the National Formulary. United States Pharmacopeial Convention, Incorporated.
6. Moghaddam M, Mehdizadeh L, Ganjeali A, Mahmoodi Sourestani M. Impact of zinc and methyl jasmonate concentrations on essential oil compositions and phytochemical constituents in Mentha piperita L. Available at SSRN 4612838. 2023.
7. Banker GS, Rhodes CT. Modern pharmaceutics 4th ed. Revised and expanded published by Marcel Dekker. 2002;121:371-8.
8. 8.Gayathri R, Kalvimoorthi V, Gopi L. FORMULATION AND EVALUATION OF OXYMETAZOLINE AS NASAL DECONGESTANT. World. 2026; p 5-2.
9. 9. Ayuhastuti A, Syah IS, Megantara S, Chaerunisaa AY. Nanotechnology-enhanced cosmetic application of kojic acid dipalmitate, a kojic acid derivate with improved properties. Cosmetics. 2024 Feb 5;11(1):21.
10. 10. Abbasi A, Chen HC. Visualizing authorship for identification. In: Lecture Notes in Computer Science (LNCS). ISI 2006. Vol. 3975. p. 60-71.
11. 11. Alburyhi MM, Saif AA, Noman MA, Al Khawlani MA. Bisoprolol-Excipient Compatibility Studies for Advanced Drug delivery Systems Development. World Journal of Pharmaceutical and Medical Research. 2024;10(10):304-24.
12. 12. Weber J, Diederichs T, Bollenbach L, Garidel P, Mäder K. Phosphatidylcholine-Polysorbate 20-Based Mixed Micelles: A New Option to Prevent Protein Aggregation?. Pharmaceutics. 2026 Mar 2;18(3):321.
13. 13. Wells JI, Aulton ME. Preformulation. In: Aulton ME, editor. Pharmaceutics: The Science of Dosage Form Design. London: Churchill Livingstone; 1988. p. 223-253.
14. 14. Dhull P, Dunuweera S, Bietsch J, Bandu R, Wannere C, Achanta S, Krishnamurthy D, Qu B, Senanayake C. Recent advances and application of liquid chromatography in pharmaceutical industry. Journal of Liquid Chromatography & Related Technologies. 2025 Jun 15;48(6-10):168-87.
15. 15 Ahuja M, Dhake AS, Sharma SK, Majumdar DK. Stability studies on aqueous and oily ophthalmic solutions of diclofenac. Yakugaku Zasshi. 2009 Apr 11;129(4):495-502.
16. 16. Mc Pherson PA, McKay B, Lowry D, McCarron PA. Exploring Tablet Dissolution with a Conductivity Probe. Journal of Chemical Education. 2026 Feb 26;103(3):1560-5.
17. 17.  Tayade B, Gharge V, Jadhav B, Patil A, Parde C, Patil S. Critical Parameters affecting Stability of APIs and Drug Products: A Review. Asian Journal of Pharmaceutical Analysis. 2026 Jan;16(1):41-50.
18. 18. Hickey AJ, Crowder TM, Louey MD, Orr N. A guide to pharmaceutical particulate science. Boca Raton (FL): CRC Press; 2003 Mar 12.
19. 19.. Alburyhi MM, El-Shaibany A. Formulation, development and evaluation of chamomile extract capsules delivery system as an advanced phytotherapy approach for gout. World Journal of Pharmaceutical and Life Sciences. 2025;11(04):215-28.
20. 20. Boateng J, Okeke O, Khan S. Polysaccharide based formulations for mucosal drug delivery: a review. Current Pharmaceutical Design. 2015 Oct 1;21(33):4798-821..
21. 21. Abdullah MM, Ahmed EA. Determination of Promethazine Hydrochloride via Area under Curve. International journal of medical and applied health science. 2025 Aug 31;1(1):32-43.
22. 22. Hermans A, Abend AM, Kesisoglou F, Flanagan T, Cohen MJ, Diaz DA, Mao Y, Zhang L, Webster GK, Lin Y, Hahn DA. Approaches for establishing clinically relevant dissolution specifications for immediate release solid oral dosage forms. The AAPS journal. 2017 Nov;19(6):1537-49.
23. 23. Zisowsky J, Krause A, Dingemanse J. Drug development for pediatric populations: regulatory aspects. Pharmaceutics. 2010 Nov 29;2(4):364-88.
24. 24. Nokhodchi A, Hentzschel CM, Leopold CS. Drug release from liquisolid systems: speed it up, slow it down. Expert opinion on drug delivery. 2011 Feb 1;8(2):191-205.
25. 25. Alburyhi MM, Noman MA, Saif AA, Alemad AF. Dispersible and Orodispersible Tablets Delivery Systems for Antibacterials Development. World Journal of Pharmaceutical Research. 2025;14(1):1229-57..
26. 26. Al Ktash M, Stefanakis M, Boldrini B, Ostertag E, Brecht M. Characterization of pharmaceutical tablets using UV hyperspectral imaging as a rapid in-line analysis tool. Sensors. 2021 Jun 28;21(13):4436.
27. 27. Ram NH, Dhondale MR, Singh M, Mishra B, Agrawal AK, Healy AM, Kumar D. The impact of crystal habit on the pharmaceutical properties of active pharmaceutical ingredients. CrystEngComm. 2025;27(27):4614-33.
28. 28. Podczeck F. A novel aid for the preparation of pellets by extrusion/spheronization. Pharmaceutical Technology Europe. 2008 Dec 1;20(12):26-31.
29. 29. Ram NH, Dhondale MR, Singh M, Mishra B, Agrawal AK, Healy AM, Kumar D. The impact of crystal habit on the pharmaceutical properties of active pharmaceutical ingredients. CrystEngComm. 2025;27(27):4614-33.
30. 30. Aliofkhazraei M, Nasar A, Chipara M, Laidani NB, De Hosson JT, editors. Handbook of modern coating technologies: applications and development. Elsevier; 2021 Mar 6.
31. 31. Loh YY, Enose AA, Garg V. Enteric-coated polymers past and present-A review. Drug Delivery Letters. 2022 Jun 1;12(2):85-95.
32. 32.  Flatie Alemu A, Tegegne AA, Getaw NS. Evaluation of Seven Different Brands of Metformin Hydrochloride Tablets Available in the Market in Gondar City, Ethiopia. Drug, Healthcare and Patient Safety. 2024 Dec 31:p 19-28.
33. 33.  Al-Ghorafi MA, Alburyhi MM, Saif AA, Noman MA. Meloxicam-Excipient Compatibility Studies for Advanced Drug Delivery Systems Development. World Journal of Pharmaceutical and Medical Research. 2025;11(1):87-106.
34. 34. Alburyhi MM, Hamidaddin MA, Noman MA, Saif AA, Yahya TA, Al-Ghorafi MA. Rivaroxaban-Excipient Compatibility Studies for Advanced Drug delivery Systems Development. European Journal of Pharmaceutical and Medical Research. 2024;11(9):370-404.
35. 35.. Dong MW. Drug Development Process: Nonclinical Development of Small Molecule Drugs. LCGC North Am. 2022 Oct 1;40(10):484-92.
36. 36.  Ahuja M, Dhake AS, Sharma SK, Majumdar DK. Stability studies on aqueous and oily ophthalmic solutions of diclofenac. Yakugaku Zasshi. 2009 Apr 1;129(4):495-502.
37. 37. Abdessadek M, Kharbach M, Ben-Saghroune H, El Amraoui B, Khabbal Y. Validation steps and parameters of bioanalytical methods using in clinical studies: A narrative review. Journal of Applied Pharmaceutical Science. 2023 Aug 4;13(8):068-83.
38. 38. Bartos D, Gorog S. Recent advances in the impurity profiling of drugs. Current Pharmaceutical Analysis. 2008 Nov 1;4(4):215-30.
39. 39. Bchkol DH, Mohammed OS. Review of the Controlled Drug Delivery Method, Dosage Form Categorization, and Therapeutic Impact on the Human Body. Spanish Journal of Innovation and Integrity. 2025 Feb 13;39:88-109.
40. 40.  Parveen S, Ramu A. Revolutionary advancements in fast dissolving tablets: An in-depth exploration. Int J Pharm Sci. 2023;1:427-6.
41. 41. Lindenmaier MP, Bernart MW, Brinckmann JA. Advanced methodologies for the quality control of herbal supplements and regulatory considerations. Phytochemical Analysis. 2025 Dec;36(8):2417-33.
42. 42. World Health Organization. Laboratory quality management system: handbook. World Health Organization; 2011.
43. 43. Anand OM, Yu LX, Conner DP, Davit BM. Dissolution testing for generic drugs: an FDA perspective. The AAPS journal. 2011 Sep;13(3):328-35.
44. 44. Al-Ghani A, Al-Khawlani M, Alwossabi A. Estimation of Catha Edulis-Anti-Platelet Drugs Interaction by HPLC and Using Closed-Loop Doluisio’s Method. Current Science. 2025 Aug 30;5(4):4219-30.
45. 45. Umaru OT, Adeyemi AS, Aderonmu O, Bhangu BS, Dhaliwal HS, Lim H, Aremu TO. Global pharmaceutical regulation: Comparative frameworks and operations. Pharmacy. 2026 Mar 18;14(2):50.
46. 46. Nishant DP, Bobade NN, Wankhade VP, Atram SC, Pande SD, Anuradha KS, Mahendra PA. Oral Fast Dissolving Film: A Review. Asian Journal of Pharmaceutical Research and Development. 2025 Apr 15;13(2):148-56.
47. 47.. Halko R, Pavelek D, Kaykhaii M. High performance liquid chromatography-fourier transform infrared spectroscopy coupling: a comprehensive review. Critical Reviews in Analytical Chemistry. 2026 Jan 2;56(1):167-78.
48. 48. Thanabodypath W, Chandrachai A, Chaiyo S, Chailapakul O. Industrial buyer innovation adoption model: A focus on a smartphone-based electrochemical analytical device for toxic heavy metal detection. Sustainability. 2021 Oct 23;13(21):11718.
49. 49. Boopathi G, Sangeetha S, Parthiban P, Saravanakumar A. RP-HPLC For the Simultaneous Determination Of Chlorpheniramine Maleate and Dextromethorphan Pharmaceutical Preparation. World Journal of Current Medical and Pharmaceutical Research. 2026 Mar 19:44-8.
50. 50. Jindal A, Kumar Sharma P, Kumar A. Self-nanoemulsifying drug delivery system (SNEDDS) as nano-carrier framework for permeability modulating approaches of BCS class III drug. Journal of Drug Targeting. 2025 Aug 9;33(7):1067-87..
51. 51. Watmode DS, Kubde JA, Hatwar PR, Bakal RL, Falke PB. Transdermal Drug Delivery System: A Comprehensive Review. Int. J. Pharm. Sci. Rev. Res. 2025;85:75-85.
52. 52. Jani GK, Shah DP, Prajapati VD, Jain VC. Gums and mucilages: versatile excipients for pharmaceutical formulations. Asian J Pharm Sci. 2009;4(5):309-23.
53. 53. Saif AA, Alburyhi MM, Noman MA, Yahya TA, Al-Ghorafi MA. Famotidine-Excipient Compatibility Studies for Advanced Drug delivery Systems Development. World Journal of Pharmaceutical Research. 2024 Jul 21;13(18):1346-408.
54. 54. Milinković S, Đekić L. Hypromellose-based films and film-forming systems for topical application: current status and perspective in drug delivery. Arhiv za farmaciju. 2024;74(6):709-34.
55. 55  Banerjee D, Saharan VA, Singh A. Fast‐Dissolving/‐Disintegrating Herbal Dosage Forms. Formulating Pharma‐, Nutra‐, and Cosmeceutical Products from Herbal Substances: Dosage Forms and Delivery Systems. 2025 Aug 26:219-42.        .
56. 56. . Li Z, Ye G, Wang Q, Sun CC, Fu Q. Advancing the understanding of tablet capping and lamination: a systematical review. Int J Pharm. 2026 Mar 30;.166
57. 57.  Chattoraj S, Daugherity P, McDermott T, Olsofsky A, Roth WJ, Tobyn M. Sticking and picking in pharmaceutical tablet compression: an IQ consortium review. Journal of Pharmaceutical Sciences. 2018 Sep 1;107(9):2267-82.
58. 58. Mahmoud MR, Mahgoub SM, Abdelazeem R, Abdelsatar MM, Allam AA, Alfassam HE, Radalla AM, Mahmoud R. RP-HPLC method development and validation for the quantification of prednisolone and salbutamol with their simultaneous removal from water using modified clay–activated carbon adsorbents. RSC advances. 2025;15(11):8675-95.
59. 59.  Prakash J, Srivastava S, Ray RS, Singh N, Rajpali R, Singh GN. Current status of herbal drug standards in the Indian pharmacopoeia. Phytotherapy research. 2017 Dec;31(12):1817-23.
60. 60.  Lough WJ. The distinctiveness of the British Pharmacopoeia and its relationship to other pharmacopeia. In: Specification of drug substances and products. Elsevier; 2025. p. 205-220..
61. 61.  King RE, Schwartz JB. Oral solid dosage forms. Remington’s Pharmaceutical Sciences. 1985 Apr 5;17:1603-32.
62. 62.  Upadhyay P, Chaudhary P, Upadhyay S. A review on formulation and evaluation approaches for fast release tablet. Mathews Journal of Pharmaceutical Science. 2023 Jan 25;7(1):1-13
63. 63. Nakamura S, Jinno M, Hamaoka M, Sakurada A, Sakamoto T. Effect of Powdered Cellulose Nanofiber with Different Particle Sizes on the Physical Properties of Tablets Manufactured via Direct Compression. Chemical and Pharmaceutical Bulletin. 2023 Dec 1;71(12):887-96.
64. 64. Reddy¹ H, Gowrav P, Manohar SK, Balamuralidhara V, Bangarurajan K. Generic Drug Industries. Generic Drugs: Science, Technology, Regulatory Frameworks and Socio-Economic Aspects. 2026 Apr 6:105.
65. 65. Dewi SM, Jayani NI, Rani KC. Effects of storage temperature and packaging method on the physical characteristics of gelatin-based chewable gummies made from moringa leaf extract. Food Research. 2025 Dec 1;9(6):87-94.
66. 66. Vijayakumar J, Goudarzi NM, Eeckhaut G, Schrijnemakers K, Cnudde V, Boone MN. Characterization of pharmaceutical tablets by X-ray tomography. Pharmaceuticals. 2023 May 11;16(5):733.
67. 67. Saurav S, Sharma P, Kumar A, Tabassum Z, Girdhar M, Mamidi N, Mohan A. Harnessing natural polymers for nano-scaffolds in bone tissue engineering: a comprehensive overview of bone disease treatment. Current Issues in Molecular Biology. 2024 Jan 5;46(1):585-611.
68. 68. Patel C, Suthar D, Patel H, Movaliya V, Parejiya P. Preformulation study of glimepiride: An insight for formulation and development of parenteral formulation. Journal of Pharmaceutical Research International. 2022 Feb 25;34(15b):38-49.
69. 69. Debnath S, Das M, Mondal S, Sarkar BK, Babu G. Advances in chromatography: contemporary techniques and applications. Essential Chem. 2025 Dec 31;2(1):1-27.
70. 70. Reddy¹ H, Gowrav P, Manohar SK, Balamuralidhara V, Bangarurajan K. Generic Drug Industries. Generic Drugs: Science, Technology, Regulatory Frameworks and Socio-Economic Aspects. 2026 Apr 6:105.